Skip to menu Skip to content Skip to footer
Dr Yousuf Mohammed
Dr

Yousuf Mohammed

Email: 
Phone: 
+61 7 344 37485
Mobile: 
0433853534

Overview

Background

Dr Yousuf Mohammed completed his PhD in pharmaceutics and skin drug delivery under the guidance of Associate prof Heather Benson, Prof Michael Roberts and Associate prof Tarl Prow. He has been working within the field of skin delivery at the Therapeutics Research Centre, University of Queensland - School of Medicine since 2012. His current research includes managing a five-year (2018-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations as a Principle Investigator and managing the five-year project (2014-2019) Characterization of Critical Quality Attributes for Semisolid Topical Drug Products as a Co-investigator. These projects aims to improve current regulatory guidelines for topical and transdermal semisolid products. Over the last 6 years, his work has been focused on skin penetration and skin toxicology of drugs and xenobiotics including nanoparticulate materials.

Availability

Dr Yousuf Mohammed is:
Available for supervision
Media expert

Qualifications

  • Masters (Coursework), Curtin University of Technology
  • Doctor of Philosophy, Curtin University of Technology

Research interests

  • Bioequivalence of Topical products: Elucidating the sensorial and functional characteristics of Topical Formulations

    In addition to the defined therapeutic effect caused by an active drug in a product, there is also a placebo and, potentially, a nocebo effect associated with those products. In topical products, these latter effects may account from 30% to 50% of the overall response for some products. They may also explain why some topical products with apparently identical bioavailability are associated with different patient outcomes. This application seeks to address the question of when do subtle excipient and manufacturing changes in a topical product cause a sensorial sensation by subjects that the “feel” of a product has changed either before and/or after it is applied to human skin. A second question is whether the “feel” of a product both before and after application can be quantified by instrumental rheology, tribology and texture analysis methods and whether these, in turn, can be related to the reported sensorial behaviour. We will manufacture topical formulations that systematically vary in Q1, Q2, and/or Q3 attributes and have large and borderline perceptive differences. We will then characterized these products using a range of rheology, tribology and texture analysis methods. In parallel, these products will be evaluated by perceptive testing focus groups, with controls, of their sensorial characterisation of the ‘feel’ of the products. We will then relate these sensorial findings with the variations in formulation nature, composition and manufacture, and their resulting instrumental test results. Our goals are, firstly, to understand the relationships between product nature, instrumental findings and sensorial analyses and, secondly, to derive criteria for instrument tests that indicates what product composition subjects suggest do not differ, uncertain if they differ and do differ in their sensorial behaviour. It is hoped that we can define the simplest, robust test that accurately and robustly is in line with sensory perceptions. A range of statistical methods, including (potentially) sophisticated, machine learning and deep learning tools will then be used to model the most appropriate instrumental analysis that can, with reasonable confidence predict perceptive attributes. A key outcome is a potential regulatory guideline advocating that generic products should exhibit similar sensorial behaviour as a reference listed drug product, giving boundaries in rheology, tribology and texture analysis as defined by Q1, Q2 and Q3 differences when that sensorial behaviour between topical products is likely to be different.

  • Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations

    The general requirements for generics to be considered are that the product is off-patent, contains an active ingredient in a previously approved medicine and is shown to be bioequivalent to that previously approved medicine. The fundamental forces governing the effects of topical drugs applied to the skin can be summed up in three distinct dimensions. 1. The interaction of the active pharmaceutical ingredient (API) with the excipients (formulation factors, solubility), 2. API with the skin (thermodynamic and pharmacodynamic activity) and 3. Excipient with the skin (penetration enhancement, diffusivity, irritancy). A thoughtful appreciation followed by a thorough understanding and then careful deliberations can help mitigate a number of failure modes that can arise from these three dimensions and result in disapproval of generic drug applications. However, there is an elusive fourth dimension, the psychorheology or the sensory/perceptive judgement of the rheological properties (and other organoleptic properties) that dictates the end user/consumers final acceptance of the product. Through this project we aim to develop meaningful risk mitigating methods and their scientific basis. These will encompass considering product behaviour during various stages of development/manufacturing, all the way to looking at the metamorphosing product as it is being applied to the treatment site on the skin. The development of generic topical products has been hampered by factors such as expensive clinical trials for BE assessment and application costs which get blown out due to the case by case assessment of applications. A burdensome application package is generally needed that wastes valuable resources and time on both sides of the coin. This project will ensure the much needed theoretical and practical framework that can enable a thorough yet efficient assessment of topical generic product applications.

  • Characterization of Critical Quality Attributes for Semisolid Topical Drug Products

    This US FDA funded project aims to understand the formulation-drug-skin interactions. Certain physicochemical attributes of a pharmaceutical product can be deemed as Critical Quality Attributes based on their influence of the product performance. This 5 year project goes into 16 different quality attributes and tests for their role in the performance of topical products using 22 different tests and numerous instruments and methods.

  • Toxicology of topically applied nanoparticles

    The safety of nanoparticles used in sunscreens has been a controversial international issue in recent years, in part because previous animal exposure studies generally found much higher skin absorption of zinc from dermal application of ZnO sunscreens than human studies. Our group’s work for the last several years has challenged these false alarms and through evidence based volunteer studies, provided the vital confidence boosting evidence for safe use of sunscreens. This is particularly relevant as the typical exposure to dangerous UV radiations has been on the rise.

Research impacts

Dr Yousuf Mohammed completed his PhD in pharmaceutics and skin drug delivery under the guidance of Associate prof Heather Benson, Prof Michael Roberts and Associate prof Tarl Prow. He has been working within the field of skin delivery at the Therapeutics Research Centre, University of Queensland - School of Medicine since 2012. His current research includes managing a five-year (2018-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations as a Principle Investigator and managing a four-year (2019-2023) US FDA funded project titled Bioequivalence of Topical products: Elucidating the sensorial and functional characteristics of Topical Formulations as a Principle Investigator. He is also currently managing the five-year project (2014-2019) Characterization of Critical Quality Attributes for Semisolid Topical Drug Products as a Co-investigator. These projects aims to improve current regulatory guidelines for topical and transdermal semisolid products in its second year of No Cost Extension. Over the last 6 years, his work has been focused on skin penetration and skin toxicology of drugs and xenobiotics including nanoparticulate materials.

Working on the US FDA project over the last two years has given an opportunity to showcase real world translational research. The work Yousuf and team has done has led to FDA guidance for Acyclovir creams which highlight the novel methods developed as a part of the work carried out locally in Brisbane in between TRI and other labs in the St Lucia campus.

Role of dispensers on physicochemical properties of the cream when dispensed. Difference in product performance upon dispensing from different dispensers was first identified and reported by our group and the change in cream product guidance based on this work is one of the biggest achievements. Our work over the last couple of years and specifically in the current year (July 2016- June 2017) has also identified skin and drug properties that determine product performance. Of special mention is our work on testing IVPT performance with different doses, different skin membrane types and different sampling protocols and different study durations. This a part of grant’s Aim 3 where we proposed to develop ideal IVPT conditions based on careful literature review as well as clearly thought-out experiments to investigate each parameter that can effect a products performance. Our IVPT studies have also included developing in-use product application and testing protocols and have assessed direct comparisons of CQAs with product performance.

Locally within the Australian topical and consumer product regulatory scene, Dr Mohammed’s work published in the Journal of Investigative dermatology has helped dispel false alarms regarding the safety and toxicity of ZnO nanoparticles. The story was captured by numerous (>400) printed and online media articles. This work, coming out at the peak of summer in Australia led to improved consumer confidence regarding better sun protection habits.

Works

Search Professor Yousuf Mohammed’s works on UQ eSpace

81 works between 2012 and 2024

1 - 20 of 81 works

2024

Journal Article

Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches

Kumar, Bhupendra, Jha, Laxmi Akhileshwar, Pandey, Prashant, Iqbal, Sayeda Fauzia, Thaleshwari, Saahiba, Banerjee, Kaushani, Imran, Mohammad, Anwaar, Shoaib, Subedi, Laxman, Dubey, Vishal, Mohammed, Yousuf, Panth, Nisha, Hansbro, Philip M., Paudel, Keshav Raj, Jha, Saurav Kumar and Bandyopadhyay, Amitabha (2024). Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches. Journal of Drug Delivery Science and Technology, 101 106264, 106264. doi: 10.1016/j.jddst.2024.106264

Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches

2024

Journal Article

Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes

Ghaferi, Mohsen, Alavi, Seyed Ebrahim, Phan, Khanh, Maibach, Howard and Mohammed, Yousuf (2024). Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes. Molecular Pharmaceutics. doi: 10.1021/acs.molpharmaceut.4c00211

Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes

2024

Journal Article

Impact of Different Packaging Configurations on A Topical Cream Product

Mohammed, Yousuf H., Namjoshi, S. N., Telaprolu, K. C., Jung, N., Shewan, H. M., Stokes, J. R., Benson, H. A. E., Grice, J. E., Raney, S. G., Rantou, E., Windbergs, Maike and Roberts, Michael S. (2024). Impact of Different Packaging Configurations on A Topical Cream Product. Pharmaceutical Research. doi: 10.1007/s11095-024-03772-5

Impact of Different Packaging Configurations on A Topical Cream Product

2024

Journal Article

3D Printed Microneedles for the Transdermal Delivery of NAD<sup>+</sup> Precursor: Toward Personalization of Skin Delivery

Ali, Masood, Namjoshi, Sarika, Phan, Khanh, Wu, Xiaoxin, Prasadam, Indira, Benson, Heather A. E., Kumeria, Tushar and Mohammed, Yousuf (2024). 3D Printed Microneedles for the Transdermal Delivery of NAD+ Precursor: Toward Personalization of Skin Delivery. ACS Biomaterials Science & Engineering. doi: 10.1021/acsbiomaterials.4c00905

3D Printed Microneedles for the Transdermal Delivery of NAD<sup>+</sup> Precursor: Toward Personalization of Skin Delivery

2024

Journal Article

Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies

Paudel, Keshav Raj, Singh, Manisha, De Rubis, Gabriele, Kumbhar, Popat, Mehndiratta, Samir, Kokkinis, Sofia, El-Sherkawi, Tammam, Gupta, Gaurav, Singh, Sachin Kumar, Malik, Md. Zubbair, Mohammed, Yousuf, Oliver, Brian G., Disouza, John, Patravale, Vandana, Hansbro, Philip Michael and Dua, Kamal (2024). Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies. Life Sciences, 352 122859, 122859. doi: 10.1016/j.lfs.2024.122859

Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies

2024

Journal Article

Strategic approaches in formulation development for atopic dermatitis

Kurebayashi, Alberto Keidi, Phan, Khanh, Abdoh, Ayyah, Andreo-Filho, Newton, Lopes, Patricia Santos, Mohammed, Yousuf and Leite-Silva, Vania Rodrigues (2024). Strategic approaches in formulation development for atopic dermatitis. Cosmetics, 11 (4) 113. doi: 10.3390/cosmetics11040113

Strategic approaches in formulation development for atopic dermatitis

2024

Journal Article

Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?

Jha, Saurav Kumar, Imran, Mohammad, Anwaar, Shoaib, Hansbro, Philip M, Paudel, Keshav Raj and Mohammed, Yousuf (2024). Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?. Nanomedicine, ahead-of-print (ahead-of-print), 1-4. doi: 10.1080/17435889.2024.2369495

Mesenchymal stem cell membrane-coated nanoconstructs: why have they not yet found a home in clinical practice?

2024

Journal Article

Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I—Bioequivalence of Acyclovir Topical Creams

Mohammed, Y. H., Namjoshi, S. N., Jung, N., Windbergs, M., Benson, H. A. E., Grice, J. E., Raney, S. G. and Roberts, M. S. (2024). Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I—Bioequivalence of Acyclovir Topical Creams. Pharmaceutical Research, 41 (7), 1-14. doi: 10.1007/s11095-024-03736-9

Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I—Bioequivalence of Acyclovir Topical Creams

2024

Journal Article

Gamma scintigraphy in sensing drug delivery systems

Nadaf, Arif, Jiba, Umme, Chaudhary, Arshi, Hasan, Nazeer, Adil, Mohammad, Mohammed, Yousuf Hussain, Kesharwani, Prashant, jain, Gaurav Kumar and Ahmad, Farhan Jalees (2024). Gamma scintigraphy in sensing drug delivery systems. Nuclear Engineering and Technology, 56 (10), 4423-4436. doi: 10.1016/j.net.2024.06.004

Gamma scintigraphy in sensing drug delivery systems

2024

Journal Article

Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery

Gunjal, Pradnya, Vishwas, Sukriti, Kumar, Rajan, Bashir, Bushra, Kumar, Bimlesh, Khurana, Navneet, Gulati, Monica, Gupta, Gaurav, Prasher, Parteek, Kumbhar, Popat, Disouza, John, Kuppusamy, Gowthamarajan, Mohammed, Yousuf, Dureja, Harish, Dua, Kamal and Singh, Sachin Kumar (2024). Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery. Drug Delivery and Translational Research, 14 (10), 1-17. doi: 10.1007/s13346-024-01634-6

Enhancing the oral bioavailability of fisetin: polysaccharide-based self nano-emulsifying spheroids for colon-targeted delivery

2024

Journal Article

Microsponges: Development, Characterization, and Key Physicochemical Properties

Qureshi, Sundus, Alavi, Seyed Ebrahim and Mohammed, Yousuf (2024). Microsponges: Development, Characterization, and Key Physicochemical Properties. ASSAY and Drug Development Technologies, 22 (5), 229-245. doi: 10.1089/adt.2023.052

Microsponges: Development, Characterization, and Key Physicochemical Properties

2024

Journal Article

Enhancement of drug permeation across skin through stratum corneum ablation

Abdoh, Ayyah, Liu, David and Mohammed, Yousuf (2024). Enhancement of drug permeation across skin through stratum corneum ablation. RSC Pharmaceutics, 1 (2), 151-160. doi: 10.1039/d4pm00089g

Enhancement of drug permeation across skin through stratum corneum ablation

2023

Journal Article

Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures

Hasan, Nazeer, Imran, Mohammad, Jain, Dhara, Jha, Saurav Kumar, Nadaf, Arif, Chaudhary, Arshi, Rafiya, Km, Jha, Laxmi Akhileshwar, Almalki, Waleed H., Mohammed, Yousuf, Kesharwani, Prashant and Ahmad, Farhan Jalees (2023). Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures. Environmental Research, 238 (Pt 1) 117007, 1-10. doi: 10.1016/j.envres.2023.117007

Advanced targeted drug delivery by bioengineered white blood cell-membrane camouflaged nanoparticulate delivery nanostructures

2023

Journal Article

Innovative approaches for maintaining and enhancing skin health and managing skin diseases through microbiome-targeted strategies

AL-Smadi, Khadeejeh, Leite-Silva, Vania Rodrigues, Filho, Newton Andreo, Lopes, Patricia Santos and Mohammed, Yousuf (2023). Innovative approaches for maintaining and enhancing skin health and managing skin diseases through microbiome-targeted strategies. Antibiotics, 12 (12) 1698. doi: 10.3390/antibiotics12121698

Innovative approaches for maintaining and enhancing skin health and managing skin diseases through microbiome-targeted strategies

2023

Journal Article

Porous silicon embedded in a thermoresponsive hydrogel for intranasal delivery of lipophilic drugs to treat rhinosinusitis

Bakshi, Shrishty, Pandey, Preeti, Mohammed, Yousuf, Wang, Joanna, Sailor, Michael J., Popat, Amirali, Parekh, Harendra S. and Kumeria, Tushar (2023). Porous silicon embedded in a thermoresponsive hydrogel for intranasal delivery of lipophilic drugs to treat rhinosinusitis. Journal of Controlled Release, 363, 452-463. doi: 10.1016/j.jconrel.2023.09.045

Porous silicon embedded in a thermoresponsive hydrogel for intranasal delivery of lipophilic drugs to treat rhinosinusitis

2023

Journal Article

A comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response

Jha, Saurav Kumar, Imran, Mohammad, Jha, Laxmi Akhileshwar, Hasan, Nazeer, Panthi, Vijay Kumar, Paudel, Keshav Raj, Almalki, Waleed H., Mohammed, Yousuf and Kesharwani, Prashant (2023). A comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response. Environmental Research, 236 (Pt 2) 116823, 1-37. doi: 10.1016/j.envres.2023.116823

A comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response

2023

Journal Article

Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches

Hasan, Nazeer, Nadaf, Arif, Imran, Mohammad, Jiba, Umme, Sheikh, Afsana, Almalki, Waleed H., Almujri, Salem Salman, Mohammed, Yousuf Hussain, Kesharwani, Prashant and Ahmad, Farhan Jalees (2023). Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. Molecular Cancer, 22 (1) 168, 168. doi: 10.1186/s12943-023-01854-3

Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches

2023

Journal Article

Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review

Al-Smadi, Khadeejeh, Ali, Masood, Alavi, Seyed Ebrahim, Jin, Xuping, Imran, Mohammad, Leite-Silva, Vania R. and Mohammed, Yousuf (2023). Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review. Cells, 12 (19) 2387, 1-19. doi: 10.3390/cells12192387

Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review

2023

Journal Article

Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes

Telaprolu, Krishna C., Grice, Jeffrey E., Mohammed, Yousuf H. and Roberts, Michael S. (2023). Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes. Metabolites, 13 (8) 934, 1-12. doi: 10.3390/metabo13080934

Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes

2023

Journal Article

Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells

Fatima Qizilbash, Farheen, Sartaj, Ali, Qamar, Zufika, Kumar, Shobhit, Imran, Mohammad, Mohammed, Yousuf, Ali, Javed, Baboota, Sanjula and Ali, Asgar (2023). Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells. Journal of Drug Targeting, 31 (8), 794-816. doi: 10.1080/1061186x.2023.2243403

Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells

Funding

Current funding

  • 2019 - 2025
    Elucidating Sensorial and Functional Characteristics of Topical Formulations
    United States Food and Drug Administration
    Open grant

Past funding

  • 2019 - 2023
    Bioequivalence of Topical Products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations (USFDA grant admin. by University of South Australia)
    University of South Australia
    Open grant
  • 2018 - 2021
    Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems
    United States Food and Drug Administration
    Open grant

Supervision

Availability

Dr Yousuf Mohammed is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Advanced microneedle platform for localized delivery

    This project is an exceptionally innovative combination of pharmaceutical science, materials science, nanotechnology, and clinical science to develop a state-of-the art drug delivery technology for an optimal treatment and overdose risk management of highly potent medicinal compounds. The project will trigger a paradigm shift towards safer dosing of abuse and misuse prone drugs, which suffer from unreliable bioavailability due to solubility or permeation challenges.

  • Bioequivalence of Topical products: Elucidating the Thermodynamic and Functional Characteristics of Compositionally Different Topical Formulations

    The purpose of this project is to support the research necessary to elucidate how systematic alterations to the qualitative (Q1) and/or quantitative (Q2) composition of topical formulations impacts their physical, structural, and functional properties. A key aspect of the research relates to understanding how the thermodynamic properties of a topical dosage form change as it undergoes metamorphosis during dose application and drying on the skin, how the drug's thermodynamic activity profile during the metamorphosis of the dosage form may compare between compositionally different (non-Q1 and/or non-Q2) topical formulations, and how these and other forces may modulate the rate and extent to which topically applied drugs may become available at or near their site(s) of action in the skin. Another key aspect of the research relates to identifying and understanding other potential failure modes for bioequivalence (BE) and/or therapeutic equivalence (TE) (e.g., differences in irritation potential) that may arise between compositionally different (non-Q1 and/or non-Q2) topical formulations.

  • Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations

    The purpose of this project is to support research relevant to topical semisolid drug products that will help elucidate the relationship between a product's quality attributes and its functional properties. A specific purpose is to elucidate how characterizations of the arrangement of matter, including rheological characterizations (e.g., texture analysis, tribology) may correlate with and/or be predictive of sensorial differences perceived by human subjects (or patients). Upon the successful completion of this research, it should be possible to predict, based upon product quality characterizations, whether test and reference products that may be compositionally different are likely to have a comparable look and feel, including comparable perceptions of grittiness, silky-smoothness, and cooling sensation.

Supervision history

Current supervision

  • Doctor Philosophy

    Thermodynamic dependence of Topical Formulations

    Principal Advisor

    Other advisors: Emeritus Professor Michael Roberts, Associate Professor Peter Moyle

  • Doctor Philosophy

    Development of topical delivery system (TDS): Role of intrinsic and extrinsic factors on performance

    Principal Advisor

    Other advisors: Professor Roger Wepf

  • Doctor Philosophy

    Strategies for Vitamin D transdermal supplementation

    Principal Advisor

  • Doctor Philosophy

    Transdermal delviery of NAD+ precursor molecule Nicotinamide Mononucleotide using Advanced Microneedle arrays

    Principal Advisor

  • Doctor Philosophy

    Development and Assessment of Topical Delivery Systems for Various Skin Diseases

    Principal Advisor

  • Doctor Philosophy

    Simultaneous absorption and evaporation PBPK models for topical drugs and inactive agents

    Principal Advisor

    Other advisors: Dr Abbas Shafiee

Completed supervision

Media

Enquiries

Contact Dr Yousuf Mohammed directly for media enquiries about:

  • Bioequivalence of Pharmaceutical Products
  • Cosmetics
  • Dermatology
  • FLIM
  • Healthcare products
  • Multiphoton Microscopy
  • Personal care products
  • Regulatory Guidelines
  • Rheology
  • Skin feel
  • Skin Imaging
  • Skin Toxicology
  • Topical Products
  • Toxicology
  • Tribology
  • •Drug delivery devices

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au